Damora Therapeutics Inc

Galecto Inc is a Danish clinical-stage biotechnology company dedicated to developing novel treatments for fibrotic diseases, liver conditions, and cancers. The company focuses on discovering and advancing therapies aimed at addressing significant unmet medical needs for patients worldwide. Within the healthcare sector, Galecto Inc specifically concentrates on developing small molecule inhibitors targeting galectin proteins. Its research seeks to create effective new treatment options for serious conditions, offering patients respite. Receive news and updates on the GLTO share price by adding this stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.